Bashar Ibrahim | Health | Best Researcher Award

Published on by Invention Awards

Assist. Prof . Dr. Bashar Ibrahim | Health | Best Researcher Award

suleyman demirel university, Turkey

Profile

Google Scholar

🎓 Early Academic Pursuits

Bashar Ibrahim's academic journey began with a Bachelor's degree in Microbiology from Mosul University, awarded on August 2, 2003. His deep interest in medical microbiology led him to pursue a Master's degree at Gazi University, where he completed his thesis titled "Allojenik nakil olan akut lösemili hastalarda nakil öncesi ve sonrası HEV prevalansı" under the supervision of Gülendam Bozdayı in February 2011. Furthering his scholarly pursuits, he earned a Ph.D. in Medical Microbiology (Medicine) from Eskisehir Osmangazi University in June 2016, where he conducted in-depth research on the prevalence of Campylobacter jejuni in infectious diarrheas under the guidance of Gül Durmaz.

🧪 Professional Endeavors

Dr. Bashar Ibrahim currently serves as an Assistant Professor in the Department of Pharmaceutical Microbiology at the Faculty of Pharmacy, Suleyman Demirel University, since January 11, 2020. His academic career reflects a robust engagement with the field of medical microbiology, particularly with a pharmaceutical application focus. He plays a vital role not just in academia but also in research project development and scientific collaborations at both national and international levels.

🔬 Contributions and Research Focus

His research spans infectious diseases, clinical virology, parasitology, vaccines, and the rational use of antimicrobials. His doctoral and master's theses underscore a sustained focus on pathogen prevalence in clinical settings, notably HEV in leukemia patients undergoing transplantation and Campylobacter jejuni in gastrointestinal infections. Dr. Ibrahim is also actively involved in a TĂśBÄ°TAK 1507 KOBÄ° R&D project supporting pharmaceutical innovation, where he serves as a researcher, collaborating with Principal Investigator Ahmet Arif Kurt since September 15, 2024.

🏆 Impact and Influence

In recognition of his contributions to the field, Dr. Ibrahim was honored with the Science Honor Award (Bilim Onur Ă–dĂĽlĂĽ) by the International Academy of Sciences in 2020. This prestigious accolade affirms his influence in the field of pharmaceutical microbiology and the broader scientific community.

đź“Š Academic Citations & Visibility

While citation databases and publication specifics are not listed here, Dr. Ibrahim’s award-winning recognition and project involvement suggest active engagement with peer-reviewed scientific literature. Further details on his citation metrics, h-index, or Scopus/Google Scholar profiles would enrich this section upon availability.

đź’» Technical & Research Skills

Dr. Ibrahim possesses technical expertise in microbial diagnostics, clinical microbiology, virology, sterility assurance, vaccine development, immunology lab techniques, and parasitology testing. His training spans complex laboratory methodologies used in infectious disease monitoring, sterile pharmaceutical practices, and antimicrobial resistance assessment.

đź“š Teaching Experience

With a strong commitment to education, Dr. Ibrahim has designed and delivered a range of undergraduate courses at Suleyman Demirel University. These include:

  • Infectious Diseases (Spring 2024–2025)

  • Vaccines (Spring 2024–2025 and 2022–2023)

  • Sterility, Hygiene and Asepsis in Pharmacy (Fall 2023–2024)

  • Antimicrobials and Rational Use (Fall 2023–2024)

  • Pharmaceutical Microbiology & Immunology Lab (Fall 2023–2024 and 2022–2023)

  • Clinical Microbiology and Medical Virology (Spring and Fall 2022–2023)

  • Medical Parasitology (Fall 2023–2024)

These courses, delivered in Turkish, reflect his multidisciplinary approach and dedication to practical, lab-based learning integrated with theoretical microbiological principles.

🌟 Legacy and Future Contributions

Dr. Bashar Ibrahim continues to contribute meaningfully to the future of pharmaceutical microbiology through teaching, research, and applied science collaboration. His involvement in national-level R&D, especially within TÜBİTAK’s innovation-driven ecosystem, signals a commitment to bridging academic knowledge with real-world pharmaceutical applications. His trajectory suggests increasing influence in both academic mentoring and health sciences policy research, particularly in Turkey and the broader scientific arena.

Selected Publications

  • Authors: Ali Ă–ztĂĽrk, Taylan Bozok, Merve ErdoÄźan, Bashar M.S. Ibrahim, Tugce Simsek Bozok

  • Journal: Folia Microbiologica

  • Year: Published online June 9, 2023 pubmed.ncbi.nlm.nih.gov+10scienceopen.com+10ouci.dntb.gov.ua+10

  • Authors: Bashar Ä°brahim, GĂĽl Durmaz, Mehdi Meskini Heydarlou

  • Journal: Osmangazi Tıp Dergisi (Osmangazi Journal of Medicine)

  • Year: 2020 turkmedline.net+3researchgate.net+3dergipark.org.tr+3

  • Authors: Ahmet Arif Kurt, Bashar Ibrahim

  • Journal: Celal Bayar Ăśniversitesi SaÄźlık Bilimleri EnstitĂĽsĂĽ Dergisi

  • Year: 2024 dergipark.org.tr

  • Authors: Ahmet Arif Kurt, Bashar Ä°brahim

  • Journal: Journal of Immunology and Clinical Microbiology

  • Year: 2024 ouci.dntb.gov.ua+12dergipark.org.tr+12scholar.google.com+12

  • Authors: Bashar Ä°brahim, Ahmet Arif Kurt

  • Journal: Journal of Immunology and Clinical Microbiology

  • Year: 2024

Dr. Solomon Jacob | Parasitology | Best Researcher Award

Published on by Invention Awards

Dr. Solomon Jacob | Parasitology | Best Researcher Award

Federal Ministry of Health, Nigeria.

Dr. Solomon Monday Jacob (JSM) is a seasoned Medical Parasitologist and a Chief Medical Laboratory Scientist at the Federal Ministry of Health, Nigeria. He serves as the Technical Lead for the National Schistosomiasis and Soil-Transmitted Helminthiasis Control Programme, playing a pivotal role in expanding Neglected Tropical Diseases (NTDs) control in Nigeria. With vast experience in malaria, onchocerciasis, lymphatic filariasis, and NTD research, he has contributed significantly to disease prevention strategies. He has published numerous research papers and collaborates with global organizations on healthcare innovations.

Profile

Orcid

🎓 Education

Dr. Solomon Jacob holds a PhD in Medical Laboratory Science with a specialization in Medical Parasitology. His academic journey has equipped him with in-depth knowledge of infectious diseases, epidemiology, and diagnostic techniques. In addition to his doctorate, he has undergone extensive training in Neglected Tropical Diseases (NTD) control programs, focusing on strategies for disease surveillance, prevention, and treatment. His expertise in disease epidemiology has enabled him to contribute significantly to public health initiatives, research projects, and policy development aimed at reducing the burden of NTDs in Nigeria and beyond.

🏢 Professional Experience

Dr. Solomon Jacob is a dedicated Program Officer for Neglected Tropical Diseases (NTDs) at the Federal Ministry of Health, Nigeria, where he plays a crucial role in formulating and implementing national disease control strategies. As a Chief Medical Laboratory Scientist, he leads technical initiatives for the Schistosomiasis & Soil-Transmitted Helminthiasis Control Programme, focusing on innovative approaches to diagnosis, treatment, and eradication efforts.

Beyond his government role, Dr. Jacob serves as a Researcher and Consultant, contributing to significant projects on Malaria, Onchocerciasis, Lymphatic Filariasis, and other NTDs. His work involves operational research, policy advisory, and capacity building to strengthen disease surveillance and control measures. Additionally, he is an Editorial Board Member for renowned scientific journals such as PLoS NTD and Elsevier, furthering his impact in global health research.

🔬 Research Interests

Neglected Tropical Diseases (NTDs) 🦠

Schistosomiasis & Soil-Transmitted Helminthiasis 🏥

Malaria & Vector-Borne Diseases 🦟

Onchocerciasis & Lymphatic Filariasis 🏨

Public Health & Disease Control Strategies

🏆 Awards & Recognitions

Recognized for strategic contributions to NTD control in Nigeria

Lead researcher in multiple operational health projects

Editorial Appointments with PLoS NTD, Elsevier

đź“š Selected Publications

Schistosomiasis and Soil Transmitted Helminthiasis Among School-Age Children: Impact of 3–5 Annual Rounds of Mass Drug Administration in Ekiti State, Southwest Nigeria
đź—“ 2025-03-23 | Journal article | đź“– Tropical Medicine and Infectious Disease
đź”— DOI: 10.3390/tropicalmed10040085
đź‘Ą Contributors: Solomon Monday Jacob, Jan-Carel Diehl, Gleb Vdovine, Temitope Agbana, Samuel Popoola, Satyajith Jujjavarapu, David Bell, Akande Oladimeji Ajayi, Joseph O. Fadare, Adebowale F. Akinwumi et al.

Impact of Preventive Chemotherapy on the Prevalence of Schistosomiasis and Soil-Transmitted Helminthiasis Among School-Age Children After 3–5 Effective Rounds of Annual Mass Drug Administration in Ekiti State, Southwest Nigeria
đź—“ 2025-01-27 | Preprint
đź”— DOI: 10.20944/preprints202501.1916.v1
đź‘Ą Contributors: Solomon Monday Jacob, Jan-Carel Diehl, Gleb Vdovine, Temitope Agbana, Samuel Popoola, Satyajith Jujjavarapu, David Bell, Oladimeji Ajayi, Joseph O. Fadare, Adebowale F. Akinwumi et al.

Impact of Praziquantel Mass Drug Administration after Several Rounds on Schistosomiasis Among School-Aged Children in Abuja, Nigeria
đź—“ 2025-01-22 | Preprint
đź”— DOI: 10.20944/preprints202501.1625.v1
đź‘Ą Contributors: Solomon Monday Jacob, Sophie Y. Akinbo, Akinola Stephen Oluwole, Temitope Agbana, Zainab Omoruyi, Michael A. Okungbowa, Diehl Jan-Carel, Fredrick O. Akinbo

Community Mobilisation for Human Sample Collection in Sensitive Communities: Experiences from Granular Mapping of Schistosomiasis and Soil-Transmitted Helminths in Ekiti State, South West, Nigeria
đź—“ 2024-10-25 | Journal article | đź“– Tropical Medicine and Infectious Disease
đź”— DOI: 10.3390/tropicalmed9110255
đź‘Ą Contributors: Temitope Agbana, Omolade Omotade, Moses Aderogba, David Bell, Jacob Solomon, Saheed Animashaun, Peace Alabi, Oladimeji Ajayi, Adebowale Akinwumi, Samuel Popoola et al.

Community Mobilisation for Human Sample Collection in Sensitive Communities: Experiences from Granular Mapping of Schistosomiasis & Soil-Transmitted Helminths in Ekiti State, Nigeria
đź—“ 2024-09-16 | Preprint
đź”— DOI: 10.20944/preprints202409.1200.v1
đź‘Ą Contributors: Temitope Agbana, Omolade Omotade, Moses Aderogba, David Bell, Jacob Solomon, Saheed Animashaun, Peace Alabi, Oladimeji Ajayi, Adebowale Akinwumi, Samuel Popoola et al.

 

 

 

Dr. Nik Kuznetsov | Aging biology | Best Researcher Award

Published on by Invention Awards

Dr. Nik Kuznetsov | Aging biology | Best Researcher Award

KI, UAEU, Sweden.

Dr. Nik Kuznetsov is a molecular biologist with extensive expertise in genomics, transcriptomics, and molecular diagnostics. With a Ph.D. in Molecular Biology, he has contributed significantly to biomedical research, space medicine, and drug discovery. His work spans gene expression profiling, biomarker discovery, personalized medicine, and microgravity research, with applications in immunology, aging, and neuroscience. Currently, he serves as a Senior Visiting Research Scientist at the United Arab Emirates University, continuing his cutting-edge research in human health and space biology.

Profile

Google Scholar

🎓 Education

Nik Kuznetsov holds a Ph.D. in Molecular Biology, where he specialized in advanced genomic applications and molecular mechanisms in cellular responses. Prior to this, he earned an M.Sc. in Biochemistry, gaining expertise in protein interactions, enzymatic pathways, and molecular signaling. His academic foundation was built with a B.Sc. in Cell Biology, focusing on cellular structures, genetic regulation, and biochemical processes. His multidisciplinary education has enabled him to contribute significantly to research in molecular genetics, bioinformatics, and space biomedicine.

🧪 Professional Experience

A highly experienced molecular biologist, currently serving as a Senior Visiting Research Scientist at United Arab Emirates University, with a strong background in molecular genetics, biotechnology, and drug discovery. Previously, he worked as a Senior Research Specialist & Lab Manager at Karolinska Institute, Sweden (2014–2022), where he managed laboratory operations and contributed to cutting-edge biomedical research. His industry experience includes serving as a Senior Scientist in Drug Discovery & Development at InDex Pharmaceuticals, Sweden (2012–2013) and as a Research Scientist at InDex Pharmaceuticals AB & InDex Diagnostics AB (2002–2011), where he played a crucial role in molecular diagnostics and therapeutic innovations. His academic career began with postdoctoral fellowships at the Karolinska Institute (1999–2001) and the Marie Curie Research Institute, UK (1997–1998), supported by the Royal Society. His expertise encompasses molecular biology, biochemistry, and cell biology, with a strong focus on translational research and pharmaceutical development.

🔬 Research Interests

Genomics & Transcriptomics: RNA-seq, ChIP-seq, RIP-seq, gene expression profiling

Molecular Biology & Bioinformatics: DNA-protein interactions, biomarker discovery

Space Biology & Aging: T-cell response in microgravity, neurodegeneration in astronauts

Personalized Medicine: Drug discovery, nucleic acid-based therapies

Immunology & Inflammation: Role of T-cells in disease and adaptive immune responses

🏆 Awards & Fellowships

2023: Best Presentation Award, UAE Microbiome 2023, Abu Dhabi, UAE

2018 – 2021: Swedish National Space Agency Research Grant, Sweden

2015 – 2020: Travel Grant Awards, Karolinska Institute, Sweden

1997 – 1998: Royal Society Postdoctoral Fellowship, UK

đź“š Selected Publications

Kuznetsov NV (2025). Expression of the p53 network aging-associated genes "shaken, not stirred" in a 3-week microgravity simulation human study. bioRxiv.

Kuznetsov NV, et al. (2025). An Update on Neuroaging on Earth and in Spaceflight. IJMS.

Kuznetsov NV, et al. (2025). Hallmarks of Brain Plasticity. Biomedicines.

Kuznetsov NV, et al. (2023). Reappraisal of the concept of accelerated aging in neurodegeneration and beyond. Cells.

Kuznetsov NV, et al. (2023). Exposure of volunteers to microgravity by dry immersion results in gene expression changes and adaptation of T cells. Science Advances.

 

 

Prof. Junyu Zhou | Medical and Prevention | Young Scientist Award

Published on by Invention Awards

Prof. Junyu Zhou | Medical and Prevention | Young Scientist Award

Peking University, China.

Prof. Junyu Zhou is a pioneering researcher in nutritional genomics, metabolic disorders, and personalized medicine. He leverages bioinformatics, computational biology, and experimental approaches to explore gene-diet interactions, focusing on Asian populations. His innovative work includes developing AI models for bioactive compound prediction and uncovering gut microbiota's role in metabolic health. Junyu's recent research extends to natural compound discovery for neurodegenerative diseases, emphasizing computational screening with advanced AI techniques.

Profile

Scopus

Orcid

Education 🎓

Junyu Zhou holds advanced degrees in fields related to nutritional genomics and computational biology. His academic training provides a strong foundation for his cutting-edge research in metabolic disorders and personalized medicine.

Experience đź’Ľ

As an Assistant Researcher at Peking University, Junyu Zhou has led and collaborated on multiple groundbreaking projects. His experience spans computational modeling, experimental validations, and interdisciplinary collaborations with global research teams in metabolic diseases and nutritional genomics.

Research Interests 🔬

Nutritional Genomics 🧬

Junyu Zhou investigates gene-diet interactions to understand how genetic variations influence nutritional responses, particularly in Asian populations. His work aims to develop personalized dietary recommendations to improve health outcomes.

Metabolic Diseases đź©ş

Focusing on conditions such as diabetes and obesity, Junyu studies the underlying mechanisms of metabolic disorders. His research integrates genetics and gut microbiota to unveil new therapeutic targets.

Computational Biology & Bioinformatics đź’»

Junyu applies advanced computational tools to analyze genetic data and predict drug-target interactions. His expertise in bioinformatics helps bridge data science and biology for innovative discoveries.

Gut Microbiota 🌱

Exploring the role of gut microbiota in metabolic health, Junyu's research uncovers microbial contributions to diseases and identifies probiotic strategies for improved metabolic functions.

Natural Product Research 🌿

Junyu's work includes computational screening of natural compounds, focusing on their potential to treat diseases such as Alzheimer's and neurodegenerative disorders.

Personalized Medicine đź©ą

By integrating genomics and computational biology, Junyu develops precision healthcare approaches, tailoring interventions to individual genetic and metabolic profiles.

Machine Learning in Drug Discovery 🤖

Junyu employs AI-driven techniques to streamline drug discovery processes. His work includes predictive models for bioactive compounds, enhancing efficiency in identifying new therapeutic agents.

Publications Top Notes đź“š

Microbial Dysbiosis Linked to Metabolic Dysfunction-Associated Fatty Liver Disease in Asians: Prevotella copri Promotes Lipopolysaccharide Biosynthesis and Network Instability in the Prevotella Enterotype, Published in: International Journal of Molecular Sciences, 2024, Contributors: Yuan, H.; Wu, X.; Wang, X.; Zhou, J.-Y.; Park, S. Link

Predicting structure-targeted food bioactive compounds for middle-aged and elderly Asians with myocardial infarction: insights from genetic variations and bioinformatics-integrated deep learning analysis, Published in: Food & Function, 2024, Contributors: Junyu Zhou; Heng Yuan; Sunmin Park. Link

Association of Metabolic Diseases and Moderate Fat Intake with Myocardial Infarction Risk, Published in: Nutrients, December 11, 2024, Contributors: Junyu Zhou; Meiling Liu; Sunmin Park. Link